Review-type articles (see below)
on methods, including their development, applicability and present status; these are usually invited by the Reviews Editor but interested
authors may contact him at mogorman@childrensmemorial.org to discuss ideas or present an outline Research reports,
full-length articles describing original work; Technical notes (short communications and application notes, being 4 pages
of type plus up to 10 references and 2-3 display items); Letters to the editors - in order to expedite publication of the
letters no proofs will be sent to the authors; Computational Modelling articles - articles dealing with the uses of computers
and modelling techniques in facilitating immunological research, and appropriate for on-line publication, should be submitted to the
Section Editor, Stephen J. Merrill Book reviews, News and announcements are welcomed.
For submission,
Review articles only should be submitted to the Reviews Editor, Dr. O'Gorman, Computational Modelling papers only should be submitted
to the Section Editor, Dr. Merrill and all other types of articles may be submitted to either of the Editors-in-Chief, Dr. M. Nussenzweig
or Prof. M. Turner.
Review articles
There are 2 types of reviews published by JIM. In general these manuscripts are
by editorial invitation however anyone interested in submitting a review can contact the Reviews Editor (mogorman@childrensmemorial.org)
and provide an outline of the proposed review. The Reviews Editor will determine suitability and suggest the appropriate format (either
a Short Analytical Review or a Full Review Format as detailed below). Reviews may encompass clinical, applied and basic research in immunology
from academia, industry and clinical operations in humans and animals.
1. Short Analytical Reviews (SARs)
Usually
not greater than 15 double spaced pages (exclusive of references) with up to 4 figures/tables and less than 40 references. These SARs
should be quite specific and critical regarding a specific methodological concern, and not an attempt to provide a comprehensive treatise
on the subject matter. They could include. For example, a: review of a new technique/technology, a new analysis method (e.g. statistical
or software application), validation/evaluations, clinical trial outcomes of new biologics, new animal models. etc.
2. Full
Reviews
Full reviews will cover a particular issue in depth with a comprehensive review of the literature. Manuscripts can
be any length but are not to exceed 40 double spaced pages (exclusive of references). The liberal use of Figures is strongly encouraged.
There is no limit on the number of references. It is expected that a full length review will provide an up to date, comprehensive treatise
on the subject matter with detailed citations to direct readers to the appropriate original work.
Online submission of papers
Authors are requested to submit their manuscripts electronically, by using the EES submission tool at http://ees.elsevier.com/jim/.
After registration, authors will be asked to upload their article and associated artwork. The submission tool will generate a PDF file
to be used for the reviewing process. The submission tool generates an automatic reply which incorporates the manuscript number for future
correspondence. Full instructions on how to use the online submission tool are available at the above web address. For those authors
who cannot submit via EES, please refer to the appropriate Editor as he/she may be able to assist with the (technical) submission problem.
Submission of Papers
Submission of a paper implies that it has not been published previously, that it is not under consideration
for publication elsewhere, and that if accepted it will not be published elsewhere in the same form, in English or in any other language,
without the written consent of the publisher. Publication shall not imply the concurrence of the Editors or Publishers with the authors'
interpretation, conclusions or validity of data.
Authors must include a cover letter that contains the title, authors, a brief
outline of the work's originality, desired section of publication, corresponding author's name, address, telephone and fax numbers (including
country and city codes), and e-mail address. All categories of submission should be submitted with a covering letter of transmittal stating
the category or section of preference in the Journal. The letter should also give the name and address of the person to whom all subsequent
correspondence should be directed.
Suggesting 4 reviewer(s) is Required for Submission
Please suggest potential reviewers
for this submission.
Use the fields below to give us contact information for each suggested reviewer, and please provide specific
reasons for your suggestion in the comments box for each person. We require 4 to 6 reviewers. Please note that the journal may not use
your suggestions, but your help is appreciated and may speed up the selection of appropriate reviewers.
Informed consent
Investigations on human subjects must include a statement indicating that informed consent was obtained after the nature and possible
consequences of the studies had been fully explained.
Animal welfare
Authors using experimental animals must state
that their care was in accordance with institutional guidelines. For animals subjected to invasive procedures, the anesthetic, analgesic
and tranquilizing agents used, as well as the amounts and frequency of administration, must be stated.
Availability of Materials
Publication of an article in the Journal of Immunological Methods is taken to imply that the authors are prepared to freely
distribute materials used in the published experiments (e.g. antibodies, cell lines) to academic researchers for their own use.
Conflict of Interest--Financial Disclosure Clause
All authors are required to inform the Editorial Office of any
financial arrangements that could be related to their manuscript, or confirm that they do not have any disclosure to make at submission.
Authors of research, review, or editorial articles should disclose to the Editors of the Journal of Immunological Methods
at the time of their submission any past, present, or pending financial arrangements of themselves or immediate family members with a
commercial company whose products are prominently presented in their article, or with a company whose products compete with those in
their article. This disclosure of financial interest will be held confidential by the Editors and will not be given to reviewers, but
if the article is accepted for publication, the Editor will ask the author how this information will be contained in the article, e.g.,
footnote disclaimer. If the author refuses the disclaimer, the Editor may not permit publication of the article.
If there
are no financial conflicts, please add the following sentence to the cover letter accompanying the submission: "None of the authors has
any potential financial conflict of interest related to this manuscript."
Page Charges
There are no page charges
for article submitted to Journal of Immunological Methods
Preparation of the text To avoid unnecessary
delays authors should adhere strictly to the following instructions.
Manuscripts should be typewritten with double spacing
and wide margins. Words to be printed in 'italics' should be underlined. The metric system is to be used throughout.
For Language
Editing assistance before submission, please link to http://www.elsevier.com/wps/find/authorsview.authors/languagepolishing
Title page
The title page should include: the title, the name(s) of the author(s), their affiliations, a footnote indicating
the author to whom correspondence and proofs should be sent stating her/his full address, telephone and fax numbers and e-mail address,
and a footnote providing the abbreviations used in the paper. Abstract
The abstract, not more than 5% of the length of
the article, will appear at the beginning of the paper. Key words
Key words should be provided at the foot of the abstract.
Normally 3-6 items should be included. Text
Follow this order when typing manuscripts: Title page Abstract, Keywords,
Main text, Acknowledgements, Appendix, References, Figure Captions and then Tables. Manuscripts dealing with experimental work should
be divided into major sections such as: Introduction, Experimental (with Materials, Methods and Results) followed by Discussion, Conclusions
and References. Do not import the Figures or Tables into your text. Footnotes should be typed at the bottom of the page on which they
appear. If a large number of abbreviations are used it is advisable to include a glossary defining such terms.
Instructions
regarding GenBank/DNA sequence linking. DNA sequences and GenBank Accession numbers
Many Elsevier journals cite
"gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further
information can be found in the database at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine.
Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should
type this information in the following manner":
For each and every accession number cited in an article, authors should
type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. (See
Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession
numbers and add the required link to GenBank's sequences.
Example 1: "GenBank accession nos. AI631510, AI631511,
AI632198, and BF223228, a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048,
and a T-cell lymphoma (GenBank accession no. AA361117)".
Authors are encouraged to check accession numbers used
very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed
article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: "GenBank
accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048),
and a T-cell lymphoma (GenBank accession no. AA361117)".
In the final version of the electronic copy, the accession
number text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article
(see Example 3 below).
Example 3: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a
B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
References
References in the text start with the name of the author(s), followed by the publication
date in brackets, e.g.: 'Larsson (1988) has shown the importance of ...', or, '... has been described (Larsson, 1988; Anderson et al.,
1996)...', using date order.
The references in the reference list should be in alphabetical order and typed double-spaced on sheets
separate from the text.
References to journals should contain names and initials of the author(s), year of publication (between brackets),
article title, abbreviation of the name of the journal according to the List of Serial Title Word Abbreviations (International
Serials Data System, 20, rue Bachaumont, 75002 Paris, France. ISBN 2-904938-02-8), volume number and page number. References to books
should also include the title (of series and volume), initials and names of the editor(s) and, between brackets, publisher and place
of publication. Periodicals, books and multi-author books should accord with the following examples:
Examples
Connolly, L., Fodey, T., Crooks, S., Delahaut, P. and Elliott, C., 2002, The production and characterisation of dinitrocarbanilide
antibodies raised using antigen mimics. J. Immunol. Methods 264, 45.
Hermanson, G.T., 1996. Bioconjugate Techniques. Academic
Press, San Diego.
Modrow, S., and Wolf, H., 1990. Use of synthetic peptides as diagnostic reagents in virology. In: M.H.V. Van
Regenmortel and A.R. Neurath (Eds.) Immunochemistry of Viruses II: The basis for serodiagnosis and vaccines. Elsevier, Amsterdam, p.83
Tables and figures
Tables should be compiled separately and numbered in Roman numerals.
Figures should be completely
lettered, the size of the lettering being appropriate, taking into account the necessary reduction in size (preferably not more than
one third). The page format should be considered in designing the figures. The figures should be numbered in Arabic numerals. Legends
should be supplied on separate sheets.
For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Colour illustrations with Colourful e-Product
Please make sure the artwork is in an acceptable format (TIFF, EPS, MS
Office files) and is at the correct resolution. If your accepted article includes colour figures then Elsevier will ensure, at no additional
charge, that these figures will appear in colour on the web (e.g., Science Direct and other sites) regardless of whether or not these
illustrations are reproduced in colour or in black and white in the printed version. For colour reproduction in print, you will receive
information regarding the costs from Elsevier after receipt of your accepted article. [Please note: Because of technical complications
which can arise by converting colour figures to "grey scale" (should you not opt for colour in printed version) please submit in addition
usable black and white prints corresponding to all the colour illustrations.]
Proofs and Offprints
One set of proofs
will be supplied electronically for the author to check for type-setting accuracy. No changes to the original manuscript will be
allowed at this stage.
Twenty-five (25) free offprints will be supplied to the corresponding author of each article. Additional
offprints and copies of the issue can be ordered at a specially reduced rate using the order form sent to the corresponding author after
the manuscript has been accepted. Orders for reprints (produced after publication of an article) will incur a 50% surcharge.
Copyright
All authors must sign the "Transfer of Copyright" agreement before the article can be published. This transfer agreement enables Elsevier
Ltd to protect the copyrighted material for the authors, without the author relinquishing his/her proprietary rights. The copyright transfer
covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microfilm or any
other reproductions of a similar nature, and translations. It also includes the right to adapt the article for use in conjunction with
computer systems and programs, including reproduction or publication in machine-readable form and incorporation in retrieval systems.
Authors are responsible for obtaining from the copyright holder permission to reproduce any material for which copyright already exists.
Author Services
For queries relating to the general submission of manuscripts (including electronic text and artwork)
and the status of accepted manuscripts, please contact Author Services, Log-in Department, Elsevier, E-mail: authors@elsevier.co.uk
Authors can also keep track of the progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's
status, by using the "Track a Paper" feature on http://www.elsevier.com/authors.
